Cardiac neurotransmission SPECT imaging

被引:52
作者
Flotats, A [1 ]
Carrió, I [1 ]
机构
[1] Hosp Santa Creu & Sant Pau, Dept Nucl Med, E-08025 Barcelona, Spain
关键词
cardiac sympathetic innervation; single photon emission computed tomography; iodine; 123; metaiodobenzylguanidine;
D O I
10.1016/j.nuclcard.2004.07.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The sympathetic nervous system has great influence on cardiovascular physiology. Cardiac neurotransmission single photon emission computed tomography (SPECT) imaging allows in vivo noninvasive assessment of presynaptic reuptake and storage of neurotransmitters, which offers characterization of the cardiac neuronal function in different diseases of the heart and other altered metabolic or functional conditions. Therefore assessment of the integrity of cardiac sympathetic innervation may help in the diagnosis of these disorders, as well as in prognostication, and will result in better therapy and outcome. At present, the most widely available SPECT tracer by which to assess cardiac neurotransmission is metaiodobenzylguanidine labeled with iodine 123. This article focuses on reviewing the characteristics of cardiac SPECT imaging with I-1.23 metaiodobenzylguanidine and its role in the assessment of pathophysiologic changes during relevant clinical conditions.
引用
收藏
页码:587 / 602
页数:16
相关论文
共 105 条
[51]  
Merlet P, 1999, J NUCL MED, V40, P917
[52]   SCINTIGRAPHIC AND ELECTROPHYSIOLOGICAL EVIDENCE OF CANINE MYOCARDIAL SYMPATHETIC DENERVATION AND REINNERVATION PRODUCED BY MYOCARDIAL-INFARCTION OR PHENOL APPLICATION [J].
MINARDO, JD ;
TULI, MM ;
MOCK, BH ;
WEINER, RE ;
PRIDE, HP ;
WELLMAN, HN ;
ZIPES, DP .
CIRCULATION, 1988, 78 (04) :1008-1019
[53]   Comparison of parameters of 123I-MIBG scintigraphy for predicting prognosis in patients with dilated cardiomyopathy [J].
Momose, M ;
Kobayashi, H ;
Iguchi, N ;
Matsuda, N ;
Sakomura, Y ;
Kasanuki, H ;
Kusakabe, K ;
Okawa, T .
NUCLEAR MEDICINE COMMUNICATIONS, 1999, 20 (06) :529-535
[54]  
Morimitsu T, 1996, J NUCL MED, V37, P1343
[55]   Investigation of the relationship between regression of hypertensive cardiac hypertrophy and improvement of cardiac sympathetic nervous dysfunction using iodine-123 metaiodobenzylguanidine myocardial imaging [J].
Morimoto, S ;
Terada, K ;
Keira, N ;
Satoda, M ;
Inoue, K ;
Tatsukawa, H ;
Katoh, S ;
Ida, K ;
Sugihara, H ;
Takeda, K ;
Nakagawa, M .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1996, 23 (07) :756-761
[56]   Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction [J].
Moss, AJ ;
Zareba, W ;
Hall, WJ ;
Klein, H ;
Wilber, DJ ;
Cannom, DS ;
Daubert, JP ;
Higgins, SL ;
Brown, MW ;
Andrews, ML .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (12) :877-883
[57]   I-123 METAIODOBENZYLGUANIDINE SCINTIGRAPHY IN THE DETECTION OF IRREGULAR REGIONAL SYMPATHETIC INNERVATION IN LONG QT SYNDROME [J].
MULLER, KD ;
JAKOB, H ;
NEUZNER, J ;
GREBE, SF ;
SCHLEPPER, M ;
PITSCHNER, HF .
EUROPEAN HEART JOURNAL, 1993, 14 (03) :316-325
[58]   Technetium 99m-labeled tetrofosmin and iodine 123-labeled metaiodobenzylguanidine scintigraphy in the assessment of transmyocardial laser revascularization [J].
Muxí, A ;
Magriñá, J ;
Martín, F ;
Josa, M ;
Fuster, D ;
Setoain, FJ ;
Pérez-Villa, F ;
Pavia, J ;
Bosch, X .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2003, 125 (06) :1493-1498
[59]  
Myerburg RJ, 1998, CIRCULATION, V97, P1514
[60]   DECREASED I-123 METAIODOBENZYLGUANIDINE UPTAKE AND INCREASED CLEARANCE IN VARIOUS CARDIAC DISEASES [J].
NAKAJIMA, K ;
TAKI, J ;
TONAMI, N ;
HISADA, K .
NUCLEAR MEDICINE COMMUNICATIONS, 1994, 15 (05) :317-323